(Q34348052)

1 August 2017

1 reference

title

Malignancy and renal disease (English)

1 reference

1 August 2017

Kapoor M

1

1 reference

1 August 2017

Chan GZ

series ordinal

2

1 reference

1 August 2017

language of work or name

1 reference

1 July 2001

1 reference

1 August 2017

published in

Critical Care Clinics

1 reference

1 August 2017

volume

17

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

571-98, viii

1 reference

Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

High-dose methotrexate: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Neoplasia and glomerular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Newer insights into cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Delayed renal failure with extensive mesangiolysis following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Steroid therapy in idiopathic retroperitoneal fibrosis: report of two successful cases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

ABC of monitoring drug therapy. Aminoglycoside antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

THE KIDNEY IN CIRRHOSIS. I. CLINICAL AND BIOCHEMICAL FEATURES OF AZOTEMIA IN HEPATIC FAILURE.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Contrast nephropathy in patients with impaired renal function: high versus low osmolar media

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Renal magnesium wasting associated with amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Single or multiple daily doses of aminoglycosides: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Segmental characterization of defects in collecting tubule acidification

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Studies on renal function after relief of complete unilateral ureteral obstruction of three months' duration in man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Diuresis and renal functional recovery in chronic retention

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Low fractional excretion of sodium in acute renal failure: role of timing of the test and ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Prevention of postoperative renal failure in patients with obstructive jaundice--the role of bile salts

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Clinical course of late-onset bone marrow transplant nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Renal toxicity of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Interventions in clinical acute renal failure: what are the data?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Atrial natriuretic peptide and dopamine in established acute renal failure in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Differences in vascular reactivity in models of ischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Renal tubular function in patients treated with high-dose cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Aminoglycoside nephrotoxicity in obstructive jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Continuous renal replacement therapies in sepsis: where are the data?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Letter: Renal disorders in hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Attenuation of experimental tobramycin nephrotoxicity by ticarcillin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Increased Sympathetic Nervous Activity and the Effects of Its Inhibition with Clonidine in Alcoholic Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Continuous hemofiltration in the treatment of acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Light-chain deposition disease: its relation with AL-type amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Renal function following acute renal failure in childhood: a long term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Renal function after release of chronic unilateral hydronephrosis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Acute renal failure complicating aortic aneurysm surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Effect of the dialysis membrane in the treatment of patients with acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Use of dexamethasone for ureteric obstruction in advanced prostate cancer: percutaneous nephrostomies can be avoided

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

In-vivo and in-vitro studies on the effect of amphotericin B on endothelin release

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Non-operative management of retroperitoneal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Improvement in renal function in hepatorenal syndrome with N-acetylcysteine.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Hemodialysis and enzymatic cleavage of methotrexate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Aminoglycoside nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

The use of probenecid as a chemoprotector against cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: a prospective randomised multicentre trial. International Multicentre Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

The pharmacology and clinical use of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Regional citrate anticoagulation in continuous venovenous hemodiafiltration.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Influence of renal shielding on the incidence of late renal dysfunction associated with T-lymphocyte deplete bone marrow transplantation in adult patients COLLEEN

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Effect of salt supplementation on amphotericin B nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Renal effects of amphotericin B lipid complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

The obstructive diuresis renogram: an appraisal of the significance

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Fanconi syndrome in adults. A manifestation of a latent form of myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Continuous renal replacement therapies: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Renal magnesium wasting and hypocalciuria in chronic cis-platinum nephropathy in man

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Multiple myeloma and contrast media

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Acute renal failure with preserved renal plasma flow induced by cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Ifosfamide nephrotoxicity in children: histopathological features in two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Hemodynamically mediated acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Epidemiology of symptomatic hypotension in hemodialysis: is cool dialysate beneficial for all patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Successful treatment of cisplatin-induced hemolytic uremic syndrome with therapeutic plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Inhibition of tobramycin reabsorption in nephron segments by metabolic alkalosis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

High-dose cisplatin with sodium thiosulfate protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Acute renal obstruction: evaluation with intrarenal duplex Doppler and conventional US

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Acute renal failure following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Phase I Clinical and Pharmacokinetic Study of Diethyldithiocarbamate as a Chemoprotector From Toxic Effects of Cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Effects of atrial natriuretic peptide in clinical acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Dopamine and Saralasin Antagonism of Renal Vasoconstriction and Oliguria Caused by Amphotericin B in Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Effect of dialyser biocompatibility on recovery from acute renal failure after cadaver renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Paraneoplastic glomerulopathies: new insights into an old entity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Isothermic hemodialysis and ultrafiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Nondilated obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Plasma exchange v peritoneal dialysis for removing Bence Jones protein

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Uptake and metabolism of cisplatin by rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Pathobiology of cast nephropathy from human Bence Jones proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Paracentesis for acute renal failure caused by hepatic veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Biocompatible membranes in acute renal failure: prospective case-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Acute renal failure due to hemolytic uremic syndrome in adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Nephrotoxicity after ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Mild ischemia predisposes the S3 segment to gentamicin toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Incidence and etiology of ifosfamide nephrotoxicity: report of a meeting held in Rhodes, Greece, October 3, 1991, sponsored by Asta Medica, Frankfurt, Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Acute renal failure after high-dose methotrexate therapy. Role of hemodialysis and plasma exchange in methotrexate removal

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Methotrexate removal during haemodialysis in a patient with advanced laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Nephron segment-specific inhibition of Na+/K(+)-ATPase activity by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Effective clearance of methotrexate using high-flux hemodialysis membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Ultrasonography in the diagnosis of renal obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Coronary angiography and acute renal failure in diabetic azotemic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

1 reference

7 January 2021

Dimethylsulphoxide-induced toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Endotoxemia, renal hypoperfusion, and fever: interactive risk factors for aminoglycoside and sepsis-associated acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Heme protein-ischemic interactions at the vascular, intraluminal, and renal tubular cell levels: implications for therapy of myoglobin-induced renal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Acute renal failure in the setting of bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Direct amphotericin B-mediated tubular toxicity: assessments of selected cytoprotective agents

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Controlled plasma exchange trial in acute renal failure due to multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970199-8

7 January 2021

10.1016/S0749-0704(05)70199-8

Identifiers

DOI

1 reference

1 August 2017

1 reference